GH Research (GHRS) Common Equity (2021 - 2026)

GH Research's Common Equity history runs 5 years deep, the most recent figure standing at $279.7 million for Q4 2025.

• In Q4 2025, Common Equity rose 56.3% year-over-year to $279.7 million; the TTM figure through Dec 2025 stood at $279.7 million (up 56.3% YoY), while the FY2025 annual figure was $279.7 million, up 56.3% from the prior year.
• Common Equity for Q4 2025 stood at $279.7 million, down from $291.4 million in the prior quarter.
• The five-year high for Common Equity was $310.2 million in Q1 2025, with the low at $179.0 million in Q4 2024.
• The 5-year median for Common Equity is $253.3 million (2022), against an average of $248.9 million.
• The sharpest annual moves came in 2024 and 2025: Common Equity retreated 18.28% in 2024, then soared 56.3% in 2025.
• GH Research's Common Equity stood at $277.2 million in 2021, then slipped by 9.87% to $249.8 million in 2022, then dropped by 12.35% to $219.0 million in 2023, then slipped by 18.28% to $179.0 million in 2024, then jumped by 56.3% to $279.7 million in 2025.
• Business Quant data shows GHRS's Common Equity at $279.7 million in Q4 2025, $291.4 million in Q3 2025, and $303.2 million in Q2 2025.